» Articles » PMID: 29961052

Induced Pluripotent Stem Cell Transplantation Improves Locomotor Recovery in Rat Models of Spinal Cord Injury: a Systematic Review and Meta-Analysis of Randomized Controlled Trials

Overview
Date 2018 Jul 2
PMID 29961052
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: Spinal cord injury (SCI) has long been a subject of great interest in a wide range of scientific fields. Several attempts have been made to demonstrate motor function improvement in rats with SCI after transplantation of induced pluripotent stem cells (iPSC). This systematic review and meta-analysis was designed to summarize the effects of iPSC on locomotor recovery in rat models of SCI.

Methods: We searched the publications in the PubMed, Medline, Science Citation Index, Cochrane Library, CNKI, and Wan-fang databases and the China Biology Medicine disc. Results were analyzed by Review Manager 5.3.0. The quality of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology.

Results: Six randomized controlled preclinical trials covering eight comparisons and including 212 rats were selected. The subgroup analyses were based on the following items: different SCI models, cell counts, iPSC sources, iPSC differentiations and transplantation methods. The pooled results indicated that iPSC transplantation significantly improved locomotor recovery of rats after SCI by sustaining beneficial effects, especially in the subgroups of contusion, moderate cell counts (5×105), source of human fetal lung fibroblasts, iPSC-neural precursors and intraspinal injection.

Conclusion: Our meta-analysis of the effects of iPSC transplantation on locomotor function in SCI models is, to our knowledge, the first meta-analysis in this field. We conclude that iPSC transplantation improves locomotor recovery in rats with SCI, implicating this strategy as an effective therapy. However, more studies are required to validate our conclusions.

Citing Articles

Improvement of spinal cord injury symptoms by targeting the Bax/Bcl2 pathway and modulating TNF-α/IL-10 using Platelet-Rich Plasma exosomes loaded with dexamethasone.

Akbari-Gharalari N, Ghahremani-Nasab M, Naderi R, Aliyari-Serej Z, Karimipour M, Shahabi P AIMS Neurosci. 2024; 10(4):332-353.

PMID: 38188010 PMC: 10767060. DOI: 10.3934/Neuroscience.2023026.


The Comparative Effects of Mesenchymal Stem Cell Transplantation Therapy for Spinal Cord Injury in Humans and Animal Models: A Systematic Review and Meta-Analysis.

Johnson L, Pickard M, Johnson W Biology (Basel). 2021; 10(3).

PMID: 33809684 PMC: 8001771. DOI: 10.3390/biology10030230.


hiPSC-derived NSCs effectively promote the functional recovery of acute spinal cord injury in mice.

Kong D, Feng B, Amponsah A, He J, Guo R, Liu B Stem Cell Res Ther. 2021; 12(1):172.

PMID: 33706803 PMC: 7953804. DOI: 10.1186/s13287-021-02217-9.


Neglected No More: Emerging Cellular Therapies in Traumatic Injury.

Lowry L, Herzig M, Christy B, Schafer R, Pati S, Cap A Stem Cell Rev Rep. 2021; 17(4):1194-1214.

PMID: 33420590 PMC: 7793620. DOI: 10.1007/s12015-020-10086-7.


Progress in Stem Cell Therapy for Spinal Cord Injury.

Gao L, Peng Y, Xu W, He P, Li T, Lu X Stem Cells Int. 2020; 2020:2853650.

PMID: 33204276 PMC: 7661146. DOI: 10.1155/2020/2853650.